Levine P A, McLean W C, Cantrell R W
Laryngoscope. 1986 Jul;96(7):742-6.
Twenty-six cases of esthesioneuroblastoma were treated by the Department of Otolaryngology-Head and Neck Surgery from 1960 to 1985. This period was divided into the precraniofacial period (1960 to 1975) and the craniofacial period (1976 to 1985) to denote the transition to a more aggressive combined therapeutic approach. Of the eight patients in the precraniofacial group (group I), only 37.5% are alive without disease. In group II (the craniofacial group), 82% of the patients are alive without disease with an average follow-up of 4 years. This latter survival rate compares favorably with the survival rate of group I and the cure rate of 10% to 67% as stated in other studies.
1960年至1985年期间，耳鼻咽喉头颈外科共治疗了26例嗅神经母细胞瘤患者。这一时期分为颅面手术前期（1960年至1975年）和颅面手术期（1976年至1985年），以表明向更积极的联合治疗方法的转变。在颅面手术前期组（第一组）的8例患者中，只有37.5%的患者存活且无疾病。在第二组（颅面手术组）中，82%的患者存活且无疾病，平均随访4年。后一组的生存率与第一组的生存率以及其他研究中所述的10%至67%的治愈率相比更具优势。
